KPRX logo

Kiora Pharmaceuticals, Inc. (KPRX)

Profile

Full Name

Kiora Pharmaceuticals, Inc.

Ticker

NASDAQ: KPRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 13, 2015

Indexes

Not included

Website

https://www.kiorapharma.com

Employees

12

Key Details

Price

$2.70(-0.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$16.02M(+100.00% YoY)

Annual EPS

$0.87(+103.59% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.70
    KPRX price is $2.70

    30-Day Relative Volume

    0.33
    KPRX 30-day relative volume is 0.33

    Price Performance

    Price Today change

    -0.37%
    KPRX price is down -0.37% today

    Price YTD change

    -18.18%
    KPRX price is down -18.18% since January 1st

    Price 1-year change

    -24.58%
    KPRX price is down -24.58% year-on-year

    Price 3-year change

    -95.97%
    KPRX price is down -95.97% over the past 3 years

    Price Range

    Price All-time high

    $145.80K
    KPRX price is currently -100.00% below its historical high of $145.80 thousand

    Price 3-year low

    $2.25
    KPRX price is currently +20.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.27M
    KPRX market capitalization is $9.27 million

    Market cap 3-year change

    +35.6%
    KPRX market capitalization is up +35.6% over the past 3 years

    Market cap All-time high

    $132.84M
    KPRX market capitalization is currently -93.02% below its historical high of $132.84 million

    Market cap sector rank

    14.29%
    KPRX market capitalization is higher than 14.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.59%
    KPRX shares outstanding is up +15.59% year-on-year

    Shares Outstanding 3-Year Change

    +3262.88%
    KPRX shares outstanding is up +3262.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.51
    KPRX beta is 0.51

    200-day SMA

    $3.15
    KPRX price is currently -14.41% below its 200-day simple moving average

    50-day SMA

    $2.78
    KPRX price is currently -2.83% below its 50-day simple moving average

    RSI

    48.92
    KPRX 14-day relative strength index is 48.92

    Volume

    0.33
    KPRX 30-day relative volume is 0.33

    ATR

    $0.14
    KPRX average true range is $0.14

    10-day Historical Volatility

    32.70%
    KPRX 10-day historical volatility is 32.70%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $16.02M
    KPRX annual revenue is $16.02 million

    Revenue Analysts estimate

    $1.50M
    KPRX annual revenue is currently +968.00% higher than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    KPRX annual revenue is up +100% year-on-year

    Revenue Sector rank

    51.37%
    KPRX annual revenue is higher than 51.37% of companies in Healthcare sector

    EPS

    EPS

    $0.87
    KPRX annual earnings per share is $0.87

    EPS Analysts estimate

    -$2.23
    KPRX annual earnings per share is currently -139.01% lower than the consensus analysts' forecast

    EPS 1-year change

    +103.59%
    KPRX annual earnings per share is up +103.59% year-on-year

    EPS Sector rank

    88.65%
    KPRX annual earnings per share is higher than 88.65% of companies in Healthcare sector

    Profit

    Gross profit

    $15.95M
    KPRX annual gross profit is $15.95 million

    Gross margin

    99.59%
    KPRX annual gross profit margin is 99.59%

    Operating profit

    $2.64M
    KPRX annual operating income is $2.64 million

    Operating margin

    16.45%
    KPRX annual operating profit margin is 16.45%

    Net income

    $3.59M
    KPRX annual net profit is $3.59 million

    Net margin

    22.44%
    KPRX annual net profit margin is 22.44%

    Expenses

    Total expenses

    $12.43M
    KPRX annual total expenses is $12.43 million

    Operating expenses

    $13.32M
    KPRX annual total operating expenses is $13.32 million

    Cost of goods sold

    $65.70K
    KPRX annual cost of goods sold is $65.70 thousand

    Selling, general & administrative expenses

    $0.00
    KPRX annual SGA is $0.00

    Depreciation and amortization

    $65.70K
    KPRX annual depreciation & amortization is $65.70 thousand

    Interest expense

    $0.00
    KPRX annual interest expense is $0.00

    Income tax

    $2.06M
    KPRX annual income tax is $2.06 million

    EBIT & EBITDA

    EBIT

    $2.64M
    KPRX annual earnings before interest & taxes is $2.64 million

    EBITDA

    $2.70M
    KPRX annual EBITDA is $2.70 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $36.48M
    KPRX annual total assets is $36.48 million

    Non current assets

    $6.78M
    KPRX annual long term assets is $6.78 million

    Current assets

    $29.71M
    KPRX annual total current assets is $29.71 million

    Cash and cash equivalents

    $26.79M
    KPRX annual cash & cash equivalents is $26.79 million

    Accounts receivable

    -
    KPRX annual accounts receivable value is unknown

    Inventory

    $0.00
    KPRX annual inventory is $0.00

    Liabilities

    Total liabilities

    $10.72M
    KPRX annual total liabilities is $10.72 million

    Long term liabilities

    $4.68M
    KPRX annual total long term liabilities is $4.68 million

    Current liabilities

    $6.01M
    KPRX annual total current liabilities is $6.01 million

    Accounts payable

    $415.60K
    KPRX annual accounts payable is $415.60 thousand

    Debt

    Total debt

    $57.20K
    KPRX annual total debt is $57.20 thousand

    Total debt 1-year change

    -46.49%
    KPRX annual total debt is down -46.49% year-on-year

    Long term debt

    $33.80K
    KPRX annual long term debt is $33.80 thousand

    Short term debt

    $23.40K
    KPRX annual short term debt is $23.40 thousand

    Equity & Capital

    Shareholders equity

    $25.76M
    KPRX annual stockholders equity is $25.76 million

    Book value

    $25.76M
    KPRX annual book value is $25.76 million

    Retained earnings

    -$143.38M
    KPRX annual retained earnings is -$143.38 million

    Working capital

    $23.70M
    KPRX annual working capital is $23.70 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $8.56M
    KPRX annual cash flow from operations is $8.56 million

    Cash from operations 1-year change

    +189.56%
    KPRX annual cash flow from operations is up +189.56% year-on-year

    Cash from investing

    -$22.66M
    KPRX annual cash flow from investing activities is -$22.66 million

    Cash from investing 1-year change

    -100%
    KPRX annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $15.50M
    KPRX annual cash flow from financing activities is $15.50 million

    Cash from financing 1-year change

    +159.77%
    KPRX annual cash flow from financing activities is up +159.77% year-on-year

    CAPEX

    CAPEX

    $6300.00
    KPRX annual capital expenditures is $6300.00

    CAPEX 1-year change

    +100%
    KPRX annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free cash flow

    $8.55M
    KPRX annual free cash flow is $8.55 million

    Free cash flow 1-year change

    +189.49%
    KPRX annual free cash flow is up +189.49% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    99.59%
    KPRX annual gross profit margin is 99.59%

    Operating margin

    16.45%
    KPRX annual operating profit margin is 16.45%

    Net margin

    22.44%
    KPRX annual net profit margin is 22.44%

    ROA & ROE

    ROA

    14.32%
    KPRX annual return on assets is 14.32%

    ROE

    22.56%
    KPRX annual return on equity is 22.56%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KPRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KPRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.42
    KPRX price to book ratio is 0.42

    PB ratio Sector rank

    22.75%
    KPRX price to book ratio is higher than 22.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    KPRX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    KPRX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$10.75M
    KPRX enterprise value is -$10.75 million

    Enterprise value Sector rank

    5.24%
    KPRX enterprise value is higher than 5.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    1.14
    KPRX EV/EBITDA is 1.14

    EV/EBITDA Sector rank

    74.04%
    KPRX EV/EBITDA is higher than 74.04% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.94
    KPRX annual current ratio is 4.94

    Quick ratio

    4.94
    KPRX annual quick ratio is 4.94

    Leverage

    Debt to equity

    0.00
    KPRX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    KPRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    KPRX piotroski f-score value is unknown

    Altman Z-Score

    -3.53
    KPRX altman z-score is -3.53

    Analyst ratings

    Recent major analysts updates

    Sep 2, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 HC Wainwright & Co.
    Buy
    Nov 12, 24 HC Wainwright & Co.
    Buy
    Aug 22, 24 HC Wainwright & Co.
    Buy
    Jul 23, 24 HC Wainwright & Co.
    Buy
    May 20, 24 HC Wainwright & Co.
    Buy
    Mar 27, 24 HC Wainwright & Co.
    Buy
    Feb 9, 24 HC Wainwright & Co.
    Buy
    Nov 13, 23 HC Wainwright & Co.
    Buy
    Nov 6, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with KPRX included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Kiora Pharmaceuticals, Inc.?
    • Does Kiora Pharmaceuticals, Inc. pay dividends?
    • What sector is Kiora Pharmaceuticals, Inc. in?
    • What industry is Kiora Pharmaceuticals, Inc. in?
    • What country is Kiora Pharmaceuticals, Inc. based in?
    • When did Kiora Pharmaceuticals, Inc. go public?
    • Is Kiora Pharmaceuticals, Inc. in the S&P 500?
    • Is Kiora Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Kiora Pharmaceuticals, Inc. in the Dow Jones?
    • When was Kiora Pharmaceuticals, Inc.'s last earnings report?
    • When does Kiora Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Kiora Pharmaceuticals, Inc.?

    The ticker symbol for Kiora Pharmaceuticals, Inc. is NASDAQ:KPRX

    Does Kiora Pharmaceuticals, Inc. pay dividends?

    No, Kiora Pharmaceuticals, Inc. does not pay dividends

    What sector is Kiora Pharmaceuticals, Inc. in?

    Kiora Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Kiora Pharmaceuticals, Inc. in?

    Kiora Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Kiora Pharmaceuticals, Inc. based in?

    Kiora Pharmaceuticals, Inc. is headquartered in United States

    When did Kiora Pharmaceuticals, Inc. go public?

    Kiora Pharmaceuticals, Inc.'s initial public offering (IPO) was on February 13, 2015

    Is Kiora Pharmaceuticals, Inc. in the S&P 500?

    No, Kiora Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Kiora Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Kiora Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Kiora Pharmaceuticals, Inc. in the Dow Jones?

    No, Kiora Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Kiora Pharmaceuticals, Inc.'s last earnings report?

    Kiora Pharmaceuticals, Inc.'s most recent earnings report was on March 31, 2025

    When does Kiora Pharmaceuticals, Inc. report earnings?

    The date for Kiora Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page